Dong Xu
Associate Director - Cell Therapy Analytical Development TScan Therapeutics
Seminars
Tuesday 2nd December 2025
Track Chair
Wednesday 3rd December 2025
Track Chair
Tuesday 2nd December 2025
Chair’s Opening Remarks
7:30 am
Wednesday 3rd December 2025
Analytical Development to Assess T-Cell Therapy Product Potency: A Matrix Approach
12:00 pm
- Understand the FDA draft guidance on cell therapy potency assurance
- Multiple mechanism of action-based assays for TCR T-cell therapies
- Matrix-based potency assessment and its implications
